CTRI/2023/09/057410已完成Unknown
Targeted Therapy in Metastatic Colorectal Cancer (mCRC) in India: A Real-world, Retrospective Observational Study - NI
Dr. Reddy’s Laboratories Ltd.0 个研究点目标入组 100 人开始时间: 待定最近更新:
试验速览
- 阶段
- Unknown
- 状态
- 已完成
- 发起方
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •Male and female patients, = 18 years of age
- •Histologically confirmed diagnosis of mCRC
- •Patients who received bevacizumab, cetuximab, or panitumumab targeted therapies for the medical management of their disease in the first-line setting
排除标准
- •Patients with follow-up data less than 6 months post-initiation of targeted therapies
- •Patients whose treatment with targeted therapy began before 2015 or more recently than 30 days prior to the ethics committee approval
研究者
相似试验
进行中（未招募）
1 期
Therapy for metastatic colorectal cancerEUCTR2011-003217-41-ATArbeitsgemeinschaft medikamentöse Tumortherapie gemeinnützige GmbH50
进行中（未招募）
1 期
A randomized phase 3 study of treatment strategies for patients with colon cancer with metastases only in the liver, which is (at this moment) not eligible for surgical treatment. A study of the Dutch Colorectal Cancer Group (DCCG).EUCTR2013-005435-24-NLDutch Colorectal Cancer Group584
招募中
3 期
Treatment strategies in colorectal cancer patients with initially unresectable liver-only metastases. CAIRO5 a randomized phase 3 study of the Dutch Colorectal Cancer Group (DCCG)Bowel Cancer10017991Colorectal cancerNL-OMON54605Dutch Colorectal Cancer Group584
终止
3 期
Tailored Treatment in Metastatic Colorectal CancerMetastatic Colorectal CancerNCT00396487Vejle Hospital1
已完成
不适用
Colorectal Cancer Umbrella Protocol - Assessment of Targeted Therapies Against Colorectal Cancer (ATTACC Program) Screening ProtocolColorectal CancerNCT01196130M.D. Anderson Cancer Center1,275